WARSAW, Ind., Oct. 01, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it sponsored the 10th Pediatric Orthopedic Surgical Techniques (POST) Course, which brought together a record 39 participants from 23 institutions across 22 … [Read more...] about OrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques Course
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
CARLSBAD, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that Tony Jarc, Ph.D. has been appointed to the newly-created position of Chief Product and AI Officer, effective immediately. Dr. Jarc will lead the development … [Read more...] about Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
Xenix Medical Announces FDA Clearance of NanoACTIV™ Surface Technology for Its Riva® Posterior Fixation System
Marks the Completion of NanoACTIV Integration Across the Company’s Entire Additively Manufactured and Wrought Titanium Spinal Implant Portfolio ORLANDO, Fla.--(BUSINESS WIRE)--Xenix Medical today announced FDA 510(k) clearance for the addition of NanoACTIV Surface Technology to the screw shanks of its Riva modular pedicle screw system, combining NanoACTIV’s osteogenic … [Read more...] about Xenix Medical Announces FDA Clearance of NanoACTIV™ Surface Technology for Its Riva® Posterior Fixation System
What Is a Spine Hub, and Why Did Avesi Invest in New Age Medical?
For the second time in five years, a private equity firm is backing the St. Louis company that links small spine manufacturers, independent reps and hospitals. The model suits today's market, but it is not without weak spots. Avesi Partners announced on September 28 that it has invested in New Age Medical, which describes itself as a "MedTech hub" for spinal surgery. Terms … [Read more...] about What Is a Spine Hub, and Why Did Avesi Invest in New Age Medical?
VB Spine Announces FDA Breakthrough Device Designation for New Blood Test Designed to Identify Patients at Risk for Scoliosis Progression
ScolimiR-3D, a novel microRNA-based blood test, is designed to enable earlier intervention and personalized management of adolescent idiopathic scoliosis based on progression risk NEW YORK--(BUSINESS WIRE)--VB Spine LLC (“VB Spine”), the largest privately-held spine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device … [Read more...] about VB Spine Announces FDA Breakthrough Device Designation for New Blood Test Designed to Identify Patients at Risk for Scoliosis Progression
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
Company Reaffirms Fiscal Year 2026 Guidance CARLSBAD, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that Richard Heppenstall has been appointed Chief Financial Officer, effective immediately. Mr. Heppenstall … [Read more...] about Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis
FDA Breakthrough Device Designated (BDD) platform engineered for durable fixation in low density bone SANTA CLARA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced U.S. Food and Drug Administration (FDA) 510(k) … [Read more...] about SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis
Neck and Neck: Is Globus Finally About to Overtake Medtronic in Spine?
When Globus closed the NuVasive deal in September 2023, plenty of people in the industry, including many on Wall Street, doubted whether it would work. The companies had very different cultures, their sales forces had spent years competing head-to-head, and the spine sector had a long history of mergers that destroyed rather than created value. Three years later, most of … [Read more...] about Neck and Neck: Is Globus Finally About to Overtake Medtronic in Spine?
Innovasis Receives FDA Clearance for Nano-Scale Surface Designation on AxTiHA, TxTiHA, and HAtetracell-C Implants
Engineered 20-nanometer surface architecture on Innovasis' HA-coated titanium implants was reviewed and cleared under the FDA's Nanotechnology Guidance, confirming nanoscale surface features with increased hydrophilicity compared to micro-rough titanium surfaces. SALT LAKE CITY, UT, September 25, 2026 (Newswire.com) - Innovasis, a privately held developer and manufacturer of … [Read more...] about Innovasis Receives FDA Clearance for Nano-Scale Surface Designation on AxTiHA, TxTiHA, and HAtetracell-C Implants
Peer-Reviewed Study Published in Spine Open Demonstrates Superior Two-Year Clinical Outcomes for FDA-Approved Synergy Disc® Compared with Cervical Fusion
The prospective U.S. IDE study found higher clinical success, reduced pain, and greater patient satisfaction with the Synergy Disc compared to ACDF, while demonstrating the alignment benefits of the device's differentiated lordotic design. LOUISVILLE, Colo., Sept. 24, 2026 /PRNewswire/ -- Synergy Spine Solutions®, a medical device company focused on … [Read more...] about Peer-Reviewed Study Published in Spine Open Demonstrates Superior Two-Year Clinical Outcomes for FDA-Approved Synergy Disc® Compared with Cervical Fusion
ATEC Appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy
Accomplished spine executive to advance ATEC's InformatiX strategy CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced that Thomas "Tommy" Carls has joined the company as Executive Vice President, Data Intelligence and Strategy. … [Read more...] about ATEC Appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy
Xenix Medical Announces FDA Clearance of the Riva® Anchor Spinopelvic Fixation System with NanoACTIV™ Surface Technology
ORLANDO, Fla.--(BUSINESS WIRE)--Xenix Medical today announced FDA 510(k) clearance for its Riva Anchor Spinopelvic Fixation System, designed to facilitate fusion of the sacroiliac (SI) joint at the base of a posterior lumbar or thoracolumbar fusion construct. The system is comprised of a Riva Anchor SI joint fusion implant that attaches to the Riva Posterior Pedicle Fixation … [Read more...] about Xenix Medical Announces FDA Clearance of the Riva® Anchor Spinopelvic Fixation System with NanoACTIV™ Surface Technology
Do Spine Companies Really Need So Many Implants? Cutting the Tray Is Not the Answer
For two decades, breadth was the proof of seriousness in spine. A catalogue that answered any anatomy, any approach and any surgeon preference was how you earned the right to be in the room. Nobody in this industry ever got promoted for killing a screw size. Portfolio rationalization is arriving in spine anyway, and it is arriving through the balance sheet rather than through … [Read more...] about Do Spine Companies Really Need So Many Implants? Cutting the Tray Is Not the Answer
SIGNUS USA® Celebrates Successful American Debut Showcasing Flagship German Spine Technology
NEW YORK CITY, NY, UNITED STATES, September 15, 2026 /EINPresswire.com/ -- SIGNUS USA today announced the successful completion of the first implantation in the United States of the COSY Cervicothoracic-Occipital Rod-Screw Spine Implant System performed by Dr. Sebastian Koga, Chief of Neurosurgery, Berkshire Health Systems, Massachusetts. This procedure marks the U.S. debut of … [Read more...] about SIGNUS USA® Celebrates Successful American Debut Showcasing Flagship German Spine Technology
Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical
CARLSBAD, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” ), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today filed a patent infringement lawsuit against DeGen Medical, Inc. (“DeGen”) in the United States District Court for the District of South Carolina Florence Division. The complaint … [Read more...] about Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical
TWIN PEAKS
The TWIN PEAKS lumbar interbody fusion system is an internal spinal fixation system intended to provide stabilization of the spine while biologic fusion occurs. The TWIN PEAKS TLIF OBLIQUE is inserted from a transforaminal approach.The TWIN PEAKS TLIF CURVED is inserted from a transforaminal approach and is rotated using a dedicated instrumentation. The TWIN PEAKS cages … [Read more...] about TWIN PEAKS
VEOS Titanium
VEOS TITANIUM is a top loading posterior osteosynthesis system that can be used in open or percutaneous/minimal invasive surgery. VEOS is part of the VEOS-KAPHORN modular platform of implants and instruments, offering a versatile solution to adapt to surgeon's needs: several specific implants and instruments modules are organized around a universal base. Fully modular, the … [Read more...] about VEOS Titanium
Globus Medical and Synaptive: Why the Rumors Deserve Attention
Rumors linking Globus Medical with Synaptive Medical have started to circulate across the industry. So far, Globus Medical has made no public announcement regarding an acquisition of the Toronto-based surgical technology company. Under normal circumstances, that would be enough to treat the story with caution. In this case, however, the rumors appear to be supported by more … [Read more...] about Globus Medical and Synaptive: Why the Rumors Deserve Attention
J&J’s $21B DePuy Synthes Bet Could End in a $20B Apollo Sale
Johnson & Johnson is negotiating the sale of DePuy Synthes, its entire orthopedics arm, to Apollo Global Management at a valuation approaching $20 billion, Bloomberg reported Friday. People familiar with the talks said an agreement could be reached within several weeks, though they cautioned that the process could still collapse, that a rival bidder could step in, or that … [Read more...] about J&J’s $21B DePuy Synthes Bet Could End in a $20B Apollo Sale